By Travis LeGuyader - October 28, 2019
High-quality science and differentiated discovery technologies coordinated by experienced industry scientists, all the way from antigen design to antibody lead. Royalty-free formats available.
We promise that we won't SPAM you.
COO of Abveris, Tracey Mullen, to Present at Antibody Engineering 2019 in San Diego
Streamlining I-O Therapeutic Antibody Discovery: An Interview with Tracey Mullen, COO of Abveris
Subscribe here for quarterly updates on new service offerings, case studies, and press releases. We'll never share your contact information externally.
Click here to join our mailing list.
480 Neponset Street, Suite 10B
Canton, MA 02021 USA
+1 (781) 562-1170